Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cranford, NJ
SEC filing record 1 source field available
Fiscal year end
30 September
Citius Pharmaceuticals, Inc. has filed 629 SEC EDGAR filings since 23 Nov 2010

SEC filing history

Showing 151-175 of 629 matching filings.

Per page
25
Current page
7
8-K File 001-38174

CURRENT REPORT

Filing date
24 Apr 2023
Reporting date
24 Apr 2023
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
03 Apr 2023
Reporting date
03 Apr 2023
Next action
Verify source filing
S-8 File 333-269703

REGISTRATION STATEMENT

Filing date
10 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
10 Feb 2023
Reporting date
10 Feb 2023
Next action
Verify source filing
10-Q File 001-38174

QUARTERLY REPORT

Filing date
10 Feb 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
4

4 filing

Filing date
09 Feb 2023
Reporting date
07 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
09 Feb 2023
Reporting date
07 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
07 Feb 2023
Reporting date
07 Feb 2023
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
22 Dec 2022
Reporting date
22 Dec 2022
Next action
Verify source filing
DEFA14A File 001-38174

DEFINITIVE ADDITIONAL MATERIALS

Filing date
22 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38174

DEFINITIVE PROXY STATEMENT

Filing date
22 Dec 2022
Reporting date
07 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-38174

ANNUAL REPORT

Filing date
22 Dec 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
01 Dec 2022
Reporting date
01 Dec 2022
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
21 Nov 2022
Reporting date
21 Nov 2022
Next action
Verify source filing
4/A

4/A filing

Filing date
15 Nov 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
28 Sep 2022
Reporting date
28 Sep 2022
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .